Fundies.
English

Advanced Biomed Inc.

EDGAR
ADVB Annual report (10-K) · filed 2026-10-13

Annual consolidated revenue for 2026: about uref_518000893 127.6K, using the latest reported figures.

Inspect reported changes Compare with another company Historical disclosures Search filings Segments
Watchlist

Latest fiscal year

Revenue

128 thousand uref_518000893

2026 · uref_518000893

Exact inputs and evidence
  • Revenue: 127637 uref_518000893 Source

Operating margin

-4,883.8%

2026 · %

Exact inputs and evidence
  • Operating Income: -6233542 uref_518000893 Source
  • Revenue: 127637 uref_518000893 Source

Operating cash flow

-1.95 million uref_518000893

2026 · uref_518000893

Exact inputs and evidence
  • Operating Cash Flow: -1946943 uref_518000893 Source
Cash and cash equivalents
Not available
Long-term debt including current maturities
Not available
Shares outstanding
1.65 million uref_1493501123 Source
Exact value

1652133 uref_1493501123

Reported share-count change

52.69% · 570 thousand uref_1493501123

Year-over-year change in reported shares. Splits, issuance and buybacks can affect this figure; it does not isolate employee compensation or economic dilution.

Exact inputs and evidence
  • 1082000 uref_1493501123 · 2025-06-30· Source
  • 1652133 uref_1493501123 · 2026-06-30· Source

Trailing twelve months

The four most recent complete quarters added together. This gives a full-year view that includes the latest quarterly results.

Net income

5.28 million USD

2025-04-01 – 2026-03-31

Exact inputs and evidence
  • Net income: -3258969 USD · 2024-07-01 – 2025-06-30 Source
  • Net income: -2557358 USD · 2024-07-01 – 2025-03-31 Source
  • Net income: -386901 USD · 2025-07-01 – 2025-09-30 Source
  • Net income: 6857921 USD · 2025-10-01 – 2025-12-31 Source
  • Net income: -488942 USD · 2026-01-01 – 2026-03-31 Source

Operating cash flow

-2.91 million USD

2025-04-01 – 2026-03-31

Exact inputs and evidence
  • Operating cash flow: -5825055 USD · 2024-07-01 – 2025-06-30 Source
  • Operating cash flow: -4281093 USD · 2024-07-01 – 2025-03-31 Source
  • Operating cash flow: -610342 USD · 2025-07-01 – 2025-09-30 Source
  • Operating cash flow: -1123900 USD · 2025-07-01 – 2025-12-31 Source
  • Operating cash flow: -610342 USD · 2025-07-01 – 2025-09-30 Source
  • Operating cash flow: -1363675 USD · 2025-07-01 – 2026-03-31 Source
  • Operating cash flow: -1123900 USD · 2025-07-01 – 2025-12-31 Source

Capital expenditure

36.1 thousand USD

2025-04-01 – 2026-03-31

Exact inputs and evidence
  • Capital expenditure: 31650 USD · 2024-07-01 – 2025-06-30 Source
  • Capital expenditure: 11501 USD · 2024-07-01 – 2025-03-31 Source
  • Capital expenditure: 1771 USD · 2025-07-01 – 2025-09-30 Source
  • Capital expenditure: 14677 USD · 2025-07-01 – 2025-12-31 Source
  • Capital expenditure: 1771 USD · 2025-07-01 – 2025-09-30 Source
  • Capital expenditure: 15941 USD · 2025-07-01 – 2026-03-31 Source
  • Capital expenditure: 14677 USD · 2025-07-01 – 2025-12-31 Source

Free cash flow

-2.94 million USD

2025-04-01 – 2026-03-31

Exact inputs and evidence
  • Operating cash flow: -5825055 USD · 2024-07-01 – 2025-06-30 Source
  • Operating cash flow: -4281093 USD · 2024-07-01 – 2025-03-31 Source
  • Operating cash flow: -610342 USD · 2025-07-01 – 2025-09-30 Source
  • Operating cash flow: -1123900 USD · 2025-07-01 – 2025-12-31 Source
  • Operating cash flow: -610342 USD · 2025-07-01 – 2025-09-30 Source
  • Operating cash flow: -1363675 USD · 2025-07-01 – 2026-03-31 Source
  • Operating cash flow: -1123900 USD · 2025-07-01 – 2025-12-31 Source
  • Capital expenditure: 31650 USD · 2024-07-01 – 2025-06-30 Source
  • Capital expenditure: 11501 USD · 2024-07-01 – 2025-03-31 Source
  • Capital expenditure: 1771 USD · 2025-07-01 – 2025-09-30 Source
  • Capital expenditure: 14677 USD · 2025-07-01 – 2025-12-31 Source
  • Capital expenditure: 1771 USD · 2025-07-01 – 2025-09-30 Source
  • Capital expenditure: 15941 USD · 2025-07-01 – 2026-03-31 Source
  • Capital expenditure: 14677 USD · 2025-07-01 – 2025-12-31 Source

Company performance

Up to ten complete financial years · consolidated figures

Includes later revisions to earlier periods. Annual charts exclude incomplete years.

Latest filing recorded: 2026-10-13.

Financial data available through: 2026-06-30.

Coverage by financial measure
  • Revenue: 1 of 11 periods available· newest 2026-06-30
  • Operating income: 2 of 11 periods available· newest 2026-06-30
  • Net income: 2 of 11 periods available· newest 2026-06-30
  • Operating cash flow: 2 of 11 periods available· newest 2026-06-30
  • Capital expenditure: 3 of 11 periods available· newest 2025-06-30
  • Total assets: 2 of 11 periods available· newest 2026-06-30
  • Total liabilities: 2 of 11 periods available· newest 2026-06-30
  • Current assets: 2 of 11 periods available· newest 2026-06-30
  • Current liabilities: 2 of 11 periods available· newest 2026-06-30
  • cash and cash equivalents: No compatible figures in this window
  • long term debt: No compatible figures in this window
  • Shares outstanding: 2 of 11 periods available· newest 2026-06-30

Coverage describes values retained in this snapshot. Missing values are not zero; loading limits are reported separately.

What changed year over year

Latest complete year compared with the corresponding period one year earlier. These are measured changes; they do not establish their business causes.

  • Net income

    +uref_518000893 9.94 million

    Prior period

    −uref_518000893 3.26 million

    –

    Current period

    uref_518000893 6.68 million

    –

    Exact inputs and evidence

    6677077 − -3258969 = 9936046 uref_518000893

    -3258969 uref_518000893 · 2024-07-01 – 2025-06-30

    Inspect prior input Prior source

    6677077 uref_518000893 · 2025-07-01 – 2026-06-30

    Inspect current input Current source
    Share or cite

    The citation records this snapshot. The page link may show a newer release later.

  • Operating cash flow

    +uref_518000893 3.88 million

    Prior period

    −uref_518000893 5.83 million

    –

    Current period

    −uref_518000893 1.95 million

    –

    Exact inputs and evidence

    -1946943 − -5825055 = 3878112 uref_518000893

    -5825055 uref_518000893 · 2024-07-01 – 2025-06-30

    Inspect prior input Prior source

    -1946943 uref_518000893 · 2025-07-01 – 2026-06-30

    Inspect current input Current source
    Share or cite

    The citation records this snapshot. The page link may show a newer release later.

Comparable inputs unavailable for: Revenue, Capital expenditure.

Where revenue goes

How a period’s revenue divides into costs and what remains as profit. Items marked Derived are calculated by subtraction from reported figures.

2026 2025-07-01 – 2026-06-30

  • Revenue uref_518000893 127,637 100% of revenue
  • Operating costs Derived uref_518000893 6.36 million 4,984% of revenue
  • Operating income −uref_518000893 6.23 million −4,884% of revenue
  • Tax, interest and other Derived −uref_518000893 12.91 million −10,115% of revenue
  • Net income uref_518000893 6.68 million 5,231% of revenue

Cash

  • Operating cash flow −uref_518000893 1.95 million −1,525% of revenue
  • Capital expenditure Unavailable An input is unavailable.
  • Free cash flow Derived Unavailable An input is unavailable.

Share of revenue by period

  • Net income
  • Tax, interest and other
  • Operating costs
  • 2026 Operating loss: operating costs were 4,984% of revenue.
Values and sources
Revenue breakdown by annual reporting period
PeriodRevenueOperating costsOperating incomeTax, interest and otherNet incomeFree cash flowSource
2026 2025-07-01 – 2026-06-30127637 6361179 Derived -6233542 -12910619 Derived 6677077 Unavailable
Source

Amounts are exact, in uref_518000893.

Growth

Sales over time and how quickly they are changing.

Revenue

Revenue reported for each complete financial period.

uref_518000893 127.6K 2026
Revenue historyRevenue reported for each complete financial period. Values are shown by financial reporting period. Open Values and sources below for the exact observations and evidence.137.8K103.4K68.9K34.5K0.02026
Values and sources
Revenue values and source evidence
PeriodSeriesValue(uref_518000893)Source evidence
2026Revenue127637

Revenue growth

Change in revenue from the same financial period one year earlier.

Not enough comparable data to show this history.
Values and sources
Revenue growth values and source evidence
PeriodSeriesValueSource evidence
2026Year over yearNo prior comparable period

Profit and cash

How much revenue becomes profit, and how much cash operations generate.

Profit margins

Operating income, net income and free cash flow as a share of revenue.

Operating margin -4,883.8% 2026
Net margin 5,231.3% 2026
Profit margins historyOperating income, net income and free cash flow as a share of revenue. Values are shown by financial reporting period. Open Values and sources below for the exact observations and evidence.6,041%3,107%174%-2,760%-5,693%2026
  • Operating margin
  • Net margin
  • Free cash flow margin
Values and sources
Profit margins values and source evidence
PeriodSeriesValueSource evidence
2026Operating margin-4,883.8%
2026Net margin5,231.3%
2026Free cash flow marginNot reported

Operating cash flow

Cash generated by the company’s normal business operations.

uref_518000893 -1.9M 2026
Operating cash flow historyCash generated by the company’s normal business operations. Values are shown by financial reporting period. Open Values and sources below for the exact observations and evidence.155.8K-408.9K-973.5K-1.5M-2.1M2026
Values and sources
Operating cash flow values and source evidence
PeriodSeriesValue(uref_518000893)Source evidence
2026Operating cash flow-1946943

Free cash flow

Operating cash flow minus capital expenditure for the same period and unit.

Not enough comparable data to show this history.
Values and sources
Free cash flow values and source evidence
PeriodSeriesValue(uref_518000893)Source evidence
2026Free cash flowUnavailable

Balance sheet

Liabilities and short-term ability to meet obligations at each period end.

Liabilities to assets

Total liabilities as a share of total assets.

10.7% 2026
Liabilities to assets historyTotal liabilities as a share of total assets. Values are shown by financial reporting period. Open Values and sources below for the exact observations and evidence.11.6%8.7%5.8%2.9%0.0%2026
Values and sources
Liabilities to assets values and source evidence
PeriodSeriesValueSource evidence
2026Liabilities / assets10.7%

Current assets to current liabilities

Current assets divided by current liabilities.

9.33× 2026
Current assets to current liabilities historyCurrent assets divided by current liabilities. Values are shown by financial reporting period. Open Values and sources below for the exact observations and evidence.10.07×7.56×5.04×2.52×0.00×2026
Values and sources
Current assets to current liabilities values and source evidence
PeriodSeriesValueSource evidence
2026Current assets / current liabilities9.33×

Cash generation

Compare reported profit with operating cash and capital spending. Free cash flow is calculated as operating cash flow minus capital expenditure when both exact, consolidated amounts match the same period and unit.

Cash generation by annual reporting period
PeriodNet incomeOperating cash flowCapital expenditureFree cash flow
2025 2024-07-01 – 2025-06-30
−uref_518000893 3.26 million
Exact value

Exact value: -3258969 uref_518000893

2024-07-01 – 2025-06-30: -3258969 uref_518000893 Inspect Net Income Open source
Share or cite

The citation records this snapshot. The page link may show a newer release later.

−uref_518000893 5.83 million
Exact value

Exact value: -5825055 uref_518000893

2024-07-01 – 2025-06-30: -5825055 uref_518000893 Inspect Operating Cash Flow Open source
Share or cite

The citation records this snapshot. The page link may show a newer release later.

Unavailable Not reported for this period.
Unavailable

Free cash flow cannot be calculated because Capital expenditure is unavailable for this period.

2026 2025-07-01 – 2026-06-30
uref_518000893 6.68 million
Exact value

Exact value: 6677077 uref_518000893

2025-07-01 – 2026-06-30: 6677077 uref_518000893 Inspect Net Income Open source
Share or cite

The citation records this snapshot. The page link may show a newer release later.

−uref_518000893 1.95 million
Exact value

Exact value: -1946943 uref_518000893

2025-07-01 – 2026-06-30: -1946943 uref_518000893 Inspect Operating Cash Flow Open source
Share or cite

The citation records this snapshot. The page link may show a newer release later.

Unavailable Not reported for this period.
Unavailable

Free cash flow cannot be calculated because Capital expenditure is unavailable for this period.

Capital expenditure uses the canonical mapped positive-spending convention. A missing, ambiguous, incompatible, or negative-sign input is left blank. Values use the latest reported version.

Dataset coverage and company identifiers

Coverage reflects filings processed into this Fundies dataset; it does not imply every source filing is loaded.

14 filings · 585 latest values · 585 originally reported values

Dataset published . Source filing dates and reporting periods are shown separately.

Identifiers: 0001941029, 1941029, ADVB, edgar:1941029

Also known as Advanced Biomed Inc, Advanced Biomed Inc.